Yang Y, Liu Y, Sun H, Meng L, Lin H, Chen C, Hu J, Shen X, Duan M, Zhang Y, Abulaiti D, Wang J, Zhu H, Hua L, Leng Q, Zhang C, Sun L, Li W, Zhu H, Liu B, Wang J. Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemia. Haematologica 2024;109(12):3965-3974; https://doi.org/10.3324/haematol.2023.284892.